• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number 71020
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Inadequate Pain Relief (2388)
Event Date 02/15/2024
Event Type  Injury  
Manufacturer Narrative
During the (b)(6) 2023 procedure the patient had been adamant about the placement of the system, despite guidance from the nalu representative working with the case.The communication issues noted after the revision appear to be directly related to the placement of the implantable components in relation to the patient anatomy and not related to the functionality of the system or its components.There are no allegations of system or component failure or malfunction.The device remains implanted and thus is unavailable for any further investigation.
 
Event Description
Patient was implanted with the nalu peripheral nerve stimulator system on (b)(6) 2023 to treat left shoulder pain.On (b)(6) 2023 the patient underwent a surgical revision to move the implant despite having good pain relief and against recommendations of medical staff (see mdr 3015425075-2023-00187).Immediately after the revision procedure, the patient was noted to have issues with communication between the implantable pulse generator (ipg) and the external therapy discs.Patient again reported receiving good therapy when the system was connected, however not receiving adequate pain relief due to the frequent disconnections when moving the left arm.On (b)(6) 2024 the firm was made aware that on (b)(6) 24 the patient underwent a surgical procedure to place a new ipg and lead.The existing ipg and lead were left implanted on the patient's lower chest wall.The new system was placed on the patient's left mid back/side area per the patient request.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NALU NEUROSTIMULATION SYSTEM
Type of Device
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
NALU MEDICAL INC
2320 faraday avenue
suite 100
calsbad CA 92008
Manufacturer (Section G)
NALU MEDICAL, INC
2320 faraday ave
suite 100
carlsbad CA 92008 7241
Manufacturer Contact
rebecca hess
2320 faraday avenue
suite 100
carlsbad, CA 92008-7241
7604482360
MDR Report Key18919263
MDR Text Key337844401
Report Number3015425075-2024-00092
Device Sequence Number1
Product Code GZF
UDI-Device Identifier00812537036182
UDI-Public01008125370361821122061617250616
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183579
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/17/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number71020
Device Catalogue Number71020
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/16/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured06/16/2022
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-